CureMatch Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 27
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.31M
Latest Deal Amount
  • Investors
  • 8

CureMatch General Information


Developer of a decision support software designed to transform cancer treatment with precision medicine. The company's software analyzes genetic information and compares it with a database of information from medical experts, other patients, clinical trials and published data to save lives and improve medical outcomes, enabling oncologists to provide customized drugs for individual patients based on their molecular tumor profile.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Outcome Management (Healthcare)
Primary Office
  • 6440 Lusk Boulevard
  • Suite D206
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

CureMatch Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CureMatch Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC $2.31M 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 17-Jul-2018 00000 00000 Completed Generating Revenue
2. Grant 07-Jun-2018 $35K Completed Generating Revenue
1. Seed Round 01-Jan-2016 Completed Generating Revenue
To view CureMatch’s complete valuation and funding history, request access »

CureMatch Executive Team (16)

Name Title Board Seat Contact Info
Razelle Kurzrock MD Co-Founder, Chief Medical Advisor & Board Member
Igor Tsigelny Ph.D Co-Founder & Advisor
Philippe Faurie Vice President, Engineering
Katie Breitenbach Chief Financial Officer
Viktor Novy Chief Technical Officer
You’re viewing 5 of 16 executive team members. Get the full list »

CureMatch Board Members (2)

Name Representing Role Since
Blaise Barrelet Self Co-Founder & Chairman 000 0000
Razelle Kurzrock MD CureMatch Co-Founder, Chief Medical Advisor & Board Member 000 0000
To view CureMatch’s complete board members history, request access »

CureMatch Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CureMatch Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Philip Trubey Angel (individual) Minority 000 0000 000000 0
Serra Ventures Venture Capital Minority 000 0000 000000 0
San Diego Regional Economic Development Corporation Other 000 0000 000000 0
Analytics Ventures Venture Capital Minority 000 0000 000000 0
Hera Fund Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »